Cardiovascular Mortality in Chronic Kidney Disease Patients Undergoing Percutaneous Coronary Intervention Is Mainly Related to Impaired P2Y12 Inhibition by Clopidogrel

Study Questions:

What is the effect of low platelet response to the P2Y12 receptor antagonist clopidogrel on outcomes in patients with or without chronic kidney disease (CKD) undergoing percutaneous coronary intervention (PCI)?